Alan Baik

Alan Baik, MD, is an Assistant Professor in the Department of Medicine at the University of California, San Francisco (UCSF). He specializes in cardio-oncology, focusing on cardiovascular care for cancer patients and survivors affected by therapy-induced heart disease. His research explores cellular responses to hypoxia and hyperoxia, particularly how oxygen levels impact cardiovascular health and disease. Dr. Baik holds prestigious awards including the Burroughs Wellcome Fund Career Award and the American Heart Association-Harold Amos Medical Faculty Development Program grant.

• Education:
  • AB in Biology, Harvard College (2008)
  • MD, UCSF School of Medicine (2014)
  • Internal Medicine Residency, UCSF (2017)
  • Cardiovascular Medicine Fellowship, UCSF (2021)
• Research Interests:

  Dr. Baik investigates cardiovascular complications from cancer therapies, including immunotherapies and targeted drugs. His work also examines cellular adaptations to extreme oxygen levels, such as hypoxia-induced signaling pathways and hyperoxia-driven toxicity. He collaborates with oncologists to develop multidisciplinary strategies for cardio-oncology care.

• Grants & Awards:
  • NIH K08 Grant (2024-2029) for studying SREBP1 as an oxygen sensor
  • Burroughs Wellcome Fund Career Award (2024-2029)
  • American Heart Association-Harold Amos Award (2024)
  • Distinguished Achievement in Science Award, Gladstone Institutes (2023)
• Publications:

  Dr. Baik has authored over 20 peer-reviewed articles, including seminal work on immune checkpoint inhibitor-associated myocarditis and oxygen toxicity mechanisms. His research bridges clinical cardio-oncology with basic science discoveries in cellular oxygen responses.

• Professional Activities:

  Serves on the American Heart Association Cardio-Oncology Committee and collaborates internationally on cardio-oncology guidelines. Leads a lab studying cardiovascular adaptations to oxygen stress.